Impact of Atrial Fibrillation Prediction Model on Prescribing Oral Anti-Coagulation in Patients With Cryptogenic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.
Also called NCT07934511
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Sponsor
- Samir Saba
- Registry
-
NCT07934511
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07934511. Allocation not applicable; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2028-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact of Atrial Fibrillation Prediction Model on Prescribing Oral Anti-Coagulation in Patients With Cryptogenic Stroke
- Condition
- Stroke
- Intervention (Device)
- UPMC AF Prediction Model
- Lead sponsor
- Samir Saba
Record details
- Record id
cardio:ct-nct07934511- Content hash
3ba6a75dee12644c373cf6f858d573d760a6d98ce6f9f04f0b155b2025196a74